NEOGENOMICS INC (NEO) Stock Income Statement
NASDAQ:NEO - Nasdaq - US64049M2098 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 672.36M | 660.57M | 591.64M | 509.70M | 484.30M | |||
| Cost Of Goods | 374.48M | 370.47M | 347.04M | 321.80M | 297.30M | |||
| Gross Profit | 297.88M | 290.10M | 244.60M | 187.90M | 187.10M | |||
| Operating Expenses | 382.98M | 375.55M | 341.25M | 341.10M | 290.10M | |||
| Research and Development | 33.72M | 29.23M | 25.19M | 28.50M | 21.20M | |||
| Selling, General, and Administrative Expenses | 335.45M | 310.49M | 279.96M | 277.90M | 229.80M | |||
| Operating Income | -85.10M | -85.45M | -96.65M | -153.10M | -103.10M | |||
| Interest Income/Expense | 10.76M | 11.81M | 9.99M | -1.50M | 104.20M | |||
| Other Income/Expense | -51.00K | -379.00K | 644.00K | -200.00K | -500.00K | |||
| Non Recurring Items | -4.26M | -6.66M | -11.09M | -4.50M | -15.70M | |||
| Income Before Taxes | -78.65M | -80.67M | -97.10M | -159.30M | -15.10M | |||
| Income Tax | -1.06M | -1.95M | -9.13M | -15.10M | -6.70M | |||
| Net Income | -77.59M | -78.73M | -87.97M | -144.30M | -8.30M | |||
| EBITDA | -13.10M | -12.90M | -24.07M | -83.67M | -49.75M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.61 | -0.62 | -0.70 | -1.16 | -0.07 | |||
| Non GAAP EPS | 0.12 | 0.10 | -0.11 | -0.56 | -0.27 | |||
| Statistics | ||||||||
| Gross Profit Margin | 44.30% | 43.92% | 41.34% | 36.86% | 38.63% | |||
| Profit Margin | -11.54% | -11.92% | -14.87% | -28.31% | -1.71% | |||
| Operating Profit Margin | -12.66% | -12.94% | -16.34% | -30.04% | -21.29% | |||
All data in USD